Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Marchex Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Marchex wird ein Gewinn- und Umsatzwachstum von 56.5% bzw. 3.9% pro Jahr prognostiziert, während der Gewinn pro Aktie um 62.1% pro Jahr wachsen soll.

Wichtige Informationen

26.2%

Wachstumsrate der Gewinne

34.4%

EPS-Wachstumsrate

Media Gewinnwachstum	12.4%
Wachstumsrate der Einnahmen	2.6%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	09 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Mar 01

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

Oct 19

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Sep 14

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:MCHX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2025	52	-4	N/A	N/A	1
12/31/2024	49	-5	N/A	N/A	2
3/31/2024	49	-7	N/A	N/A	N/A
12/31/2023	50	-10	-6	-4	N/A
9/30/2023	50	-12	-8	-7	N/A
6/30/2023	50	-12	-9	-7	N/A
3/31/2023	51	-11	-7	-5	N/A
12/31/2022	52	-8	-5	-2	N/A
9/30/2022	53	-7	-5	-2	N/A
6/30/2022	53	-2	-4	-1	N/A
3/31/2022	54	-1	-5	-2	N/A
12/31/2021	53	-4	-8	-6	N/A
9/30/2021	53	-8	-8	-7	N/A
6/30/2021	53	-16	-10	-9	N/A
3/31/2021	52	-22	-8	-7	N/A
12/31/2020	51	-42	-5	-3	N/A
9/30/2020	15	-42	-5	-4	N/A
6/30/2020	26	-39	-2	0	N/A
3/31/2020	40	-34	-4	-2	N/A
12/31/2019	54	-10	3	5	N/A
9/30/2019	101	-4	6	8	N/A
6/30/2019	96	-4	7	8	N/A
3/31/2019	90	-3	6	8	N/A
12/31/2018	85	-3	3	5	N/A
9/30/2018	84	-3	2	4	N/A
6/30/2018	86	-3	2	4	N/A
3/31/2018	88	-4	3	6	N/A
12/31/2017	90	-6	N/A	2	N/A
9/30/2017	97	-11	N/A	1	N/A
6/30/2017	106	-16	N/A	-2	N/A
3/31/2017	118	-84	N/A	-2	N/A
12/31/2016	130	-84	N/A	-4	N/A
9/30/2016	136	-77	N/A	-2	N/A
6/30/2016	142	-71	N/A	6	N/A
3/31/2016	143	-4	N/A	4	N/A
12/31/2015	143	-1	N/A	13	N/A
9/30/2015	139	-2	N/A	16	N/A
6/30/2015	150	-24	N/A	15	N/A
3/31/2015	161	-23	N/A	21	N/A
12/31/2014	174	-23	N/A	22	N/A
9/30/2014	182	-22	N/A	24	N/A
6/30/2014	175	1	N/A	22	N/A
3/31/2014	166	1	N/A	20	N/A
12/31/2013	148	-2	N/A	14	N/A
9/30/2013	145	-34	N/A	12	N/A
6/30/2013	138	-35	N/A	11	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MCHX wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: MCHX wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: MCHX wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: MCHXDie Einnahmen des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.1% pro Jahr).

Hohe Wachstumseinnahmen: MCHXDie Einnahmen des Unternehmens (3.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von MCHX in 3 Jahren voraussichtlich hoch sein wird

Marchex Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

Consensus EPS estimates fall by 29%

Consensus EPS estimates fall by 66%

Recent updates

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Marchex, Inc. Provides Revenue Guidance for the Second Quarter Ending June 30, 2024

Marchex, Inc. to Report Q1, 2024 Results on May 07, 2024

Marchex Launches Generative Ai-Powered Sentiment Suite Across Multiple Apis

Consensus EPS estimates upgraded to US$0.12 loss, revenue downgraded

Full year 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year of 2024

Marchex, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Will Marchex (NASDAQ:MCHX) Spend Its Cash Wisely?

Third quarter 2023 earnings: EPS exceeds analyst expectations

Marchex, Inc. Provides Earnings Guidance for Fourth Quarter Ending December 31, 2023 and Fiscal Year 2024

New major risk - Revenue and earnings growth

Marchex, Inc. Launches Call Summary and Sentiment Suite Capabilities for Vertical Markets

Marchex, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Is Marchex (NASDAQ:MCHX) In A Good Position To Deliver On Growth Plans?

What You Can Learn From Marchex, Inc.'s (NASDAQ:MCHX) P/SAfter Its 26% Share Price Crash

Marchex, Inc., Annual General Meeting, Sep 28, 2023

New major risk - Financial position

Second quarter 2023 earnings: EPS exceeds analyst expectations

Companies Like Marchex (NASDAQ:MCHX) Are In A Position To Invest In Growth

Consensus EPS estimates fall by 29%

First quarter 2023 earnings: EPS misses analyst expectations

Full year 2022 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 66%

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.1% to US$3.25

Marchex, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Marchex, Inc. Announces Executive Changes

We're Not Very Worried About Marchex's (NASDAQ:MCHX) Cash Burn Rate

Insufficient new directors

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Marchex, Inc. to Report Q3, 2022 Results on Nov 03, 2022

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Marchex, Inc., Annual General Meeting, Sep 29, 2022

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations

Marchex, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insufficient new directors

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Marchex, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Marchex, Inc. to Report Q1, 2022 Results on May 12, 2022

Insufficient new directors

Price target decreased to US$3.50

We're Hopeful That Marchex (NASDAQ:MCHX) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Marchex Inc. Launches Conversation Dna, Delivering Powerful Ai Signals Through Every Marchex Conversation Intelligence Product

Marchex, Inc. to Report Q4, 2021 Results on Mar 02, 2022

Price target decreased to US$4.00

Third quarter 2021 earnings released: EPS US$0.083 (vs US$0.078 loss in 3Q 2020)

Marchex: Hope Springs Eternal

Second quarter 2021 earnings released: US$0.008 loss per share (vs US$0.096 loss in 2Q 2020)

Does Marchex (NASDAQ:MCHX) Have A Healthy Balance Sheet?

Consensus EPS estimates increase to -US$0.29

Consensus EPS estimates increase to -US$0.44

First quarter 2021 earnings released: US$1.14 loss per share (vs US$0.53 loss in 1Q 2020)

Marchex, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2021

Marchex® Launches AI-powered SalesEngagement Solution

Is Marchex (NASDAQ:MCHX) Using Debt Sensibly?

How Much Of Marchex, Inc. (NASDAQ:MCHX) Do Insiders Own?

Full year 2020 earnings released: US$0.98 loss per share (vs US$0.089 loss in FY 2019)

Revenue and earnings miss expectations

Price target raised to US$4.38

Marchex, Inc. to Report Q4, 2020 Results on Mar 02, 2021

New 90-day high: US$2.99

A Look At Marchex's (NASDAQ:MCHX) Share Price Returns

Marchex Inc.: Cheap Company Expected To Grow In 2021

Marchex Launches Marketing Edge, AI-Fueled Conversational Analytics Solution that Enables Brand Marketers and Agencies to More Effectively Drive Sales Conversations